🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Studying samples of blood from patients with cancer in the labor...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2008-06-18
Trial ID
NCT00764322
Knowledge of the impact of gene expression profiling could allow optimisati...
Status
Unknown
Location
Royal Marsden Hospital
Start Date
2002-06
Trial ID
NCT00220077
Treatments Being Tested
Background The current management on rectal cancer based on TNM staging has...
Status
Unknown
Location
Azienda Ospedale Università di Padova
Start Date
2020-01-01
Trial ID
NCT04917263
Treatments Being Tested
RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
Hollings Cancer Center at Medical University of South Carolina
Start Date
2008-10
Trial ID
NCT00747305
RATIONALE: Studying samples of blood from patients with cancer in the labor...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01433237
Treatments Being Tested
RATIONALE: Studying samples of bone marrow and blood from patients with can...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00897624
RATIONALE: Finding genetic markers for thyroid cancer in a biopsy specimen ...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2005-07
Trial ID
NCT00316823
The purpose of the study is to investigate the proportion of the cell-of-or...
Status
Completed
Location
Yian Zhang
Start Date
2021-04-14
Trial ID
NCT05318391
Treatments Being Tested
RATIONALE: Azadirachta indica may be an effective treatment for chronic lym...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01251250
RATIONALE: Celecoxib may stop the growth of tumor cells by blocking some of...
Status
Unknown
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2006-06
Trial ID
NCT00357617